Arkolith/Insider Trading/CYTH/Form 4

Sieger Markus

DirectorCyclo Therapeutics, Inc. (CYTH) · full profile →Form 4 · filed Oct 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 20, 2023Option exercise(X)60K$0.71$43K280K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 20, 2023Buy(P)66K——66K
Oct 20, 2023Option exercise(X)60K$0.13$8K0

Transaction Codes

X
Exercise of in-the-money derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-028702) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML